Chinese Journal of Cancer Research

期刊全称Chinese Journal of Cancer Research
期刊缩写CHINESE J CANCER RES
涉及主题医学生物遗传学内科学病理癌症化学生物化学免疫学外科癌症研究基因肿瘤科放射科数学分子生物学物理
期刊介绍

Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631; www.thecjcr.org) is published by AME Publishing Company (www.amepc.org) in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013. CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.

期刊ISSNprint: 1000-9604
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
75.14.0265.0874.1352.5153.6893
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量365656606473886970726611812677
被引量1025228624372330209817731124728475358374378271163
h-Index0
自引率14.30%
涉及的研究领域医学-肿瘤学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
2区3区 肿瘤学否否
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
ONCOLOGYSCIEQ151/326

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
ONCOLOGYSCIEQ288/326
期刊主页https://www.springer.com/journal/11670http://springerlink.com/content/120372/?sortorder=asc&p_o=0
投稿网址https://mc03.manuscriptcentral.com/cjcr
出版商Springer Berlin Heidelberg
出版国家（地区）PEOPLES R CHINA
出版语言English
出版周期Quarterly
每年出版文章数62
Gold OA文章占比94.30%
原创研究文献占比
(排除综述)		84.09%
SCI收录类型

Science Citation Index Expanded (SCIE)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1000-9604%5BISSN%5D
平均审稿周期平均4.5月
平均录用比例约62.5%
相关链接

您可以在上述网站查看该期刊的网友互动，及期刊影响力的其它指标。

注：上述信息均来源于网络，仅供查考，如有遗漏或信息错误，欢迎 向我反馈。

期刊相关文献 (69)

Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer.

对单细胞和整体转录组的综合分析揭示了人类前列腺癌中具有临床意义的分子亚型

期刊:Chinese Journal of Cancer Research
影响因子:6.300
doi:10.21147/j.issn.1000-9604.2025.01.07
Ding Tao, He Lina, Lin Guowen, Xu Lei, Zhu Yanjun, Wang Xinan, Liu Xuefei, Guo Jianming, Lei Fanghong, Zuo Zhixiang, Zheng Jianghua
细胞生物学
前列腺癌
Human
发表日期：2025
全文求助 收藏

Targeted activation of junctional adhesion molecule-like protein+ CD8+ T cells enhances immunotherapy in hepatocellular carcinoma.

靶向激活连接粘附分子样蛋白+ CD8+ T 细胞可增强肝细胞癌的免疫治疗

期刊:Chinese Journal of Cancer Research
影响因子:6.300
doi:10.21147/j.issn.1000-9604.2025.02.08
Chen Huan, Xiao Zhaofeng, Lu Zhengyang, Xu Nan, Wei Qiang, Xu Xiao
细胞生物学
CD8
发表日期：2025
全文求助 收藏

Composite score of PD-1 (+) CD8 (+) tumor-infiltrating lymphocytes and CD57 (+) CD8 (+) tumor ascites lymphocytes is associated with prognosis and tumor immune microenvironment of patients with advanced high-grade serous ovarian cancer.

PD-1 (+) CD8 (+) 肿瘤浸润淋巴细胞和 CD57 (+) CD8 (+) 肿瘤腹水淋巴细胞的综合评分与晚期高级别浆液性卵巢癌患者的预后和肿瘤免疫微环境相关

期刊:Chinese Journal of Cancer Research
影响因子:6.300
doi:10.21147/j.issn.1000-9604.2025.01.06
He Tianhui, Zhang Jie, Zeng Lin, Yin Zhongnan, Yu Bo, Zhang Xi, Yang Xiaoxue, Shang Chunliang, Xue Lixiang, Guo Hongyan
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
全文求助 收藏

Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis

中国人群同源重组缺陷阳性非小细胞肺癌的临床和分子意义：综合基因组和转录分析

期刊:Chinese Journal of Cancer Research
影响因子:1.200
doi:10.21147/j.issn.1000-9604.2024.03.05
Yifei Wang, Yidan Ma, Lei He, Jun Du, Xiaoguang Li, Peng Jiao, Xiaonan Wu, Xiaomao Xu, Wei Zhou, Li Yang, Jing Di, Changbin Zhu, Liming Xu, Tianlin Sun, Lin Li, Dongge Liu, Zheng Wang
免疫
细胞生物学
肺癌
肿瘤细胞
发表日期：2024
全文求助 收藏

Systematic functional interrogation of genome-wide association studies locus 17p13.3 deciphered role and genetic control of FAM57A in colorectal cancer development

全基因组关联研究 17p13.3 基因座的系统功能探究揭示了 FAM57A 在结直肠癌发展中的作用和基因控制

期刊:Chinese Journal of Cancer Research
影响因子:1.200
doi:10.21147/j.issn.1000-9604.2024.05.08
Jinyu Huang, Jiabin Mo, Runying Xu, Xiaojun Yang, Yaoyao Tian, Caibo Ning, Shuxin Song, Xu Chen, Yimin Cai, Ying Zhu, Bin Li, Chaoqun Huang, Meng Jin, Xiaoping Miao
肿瘤
肠癌
发表日期：2024
全文求助 收藏

Zinc finger protein 296 promotes hepatocellular carcinoma progression via intervening interaction between macrophages and B cells

锌指蛋白296通过介入巨噬细胞与B细胞间的相互作用促进肝细胞癌进展

期刊:Chinese Journal of Cancer Research
影响因子:1.200
doi:10.21147/j.issn.1000-9604.2024.05.05
Nan Xu, Xiaonan Xiang, Huan Chen, Yiyuan Chen, Shuai Wang, Haijun Guo, Xuyong Wei, Jun Chen, Xiao Xu, Qiang Wei
免疫
细胞生物学
肝癌
B细胞
巨噬细胞
FlowCytometry
发表日期：2024
全文求助 收藏

SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis

SOX11 作为肝细胞癌的潜在预后生物标志物与免疫浸润和铁死亡有关

期刊:Chinese Journal of Cancer Research
影响因子:1.200
doi:10.21147/j.issn.1000-9604.2024.04.03
Hongyu Chen, Qiangguo Ao, Yueling Wang, Yue Qian, Qingli Cheng, Wei Zhang
细胞生物学
肿瘤
肝癌
其它细胞
发表日期：2024
全文求助 收藏

Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma

肿瘤衍生的 DEFB1 通过抑制树突状细胞成熟和损害食管鳞状细胞癌中的 CD8+ T 细胞功能来诱导免疫耐受

期刊:Chinese Journal of Cancer Research
影响因子:1.200
doi:10.21147/j.issn.1000-9604.2024.04.01
Jingjing Duan, Haotian Wang, Minglu Liu, Yin Chen, Ning Li, Jieqiong Liu, Lingxiong Wang, Lin Li, Yaru Liu, Pengfei Dong, Xiuxuan Wang, Zhongyi Fan, Shunchang Jiao
肿瘤
食管癌
T细胞
树突状细胞
发表日期：2024
全文求助 收藏

Pyrotinib is effective in both trastuzumab-sensitive and primary resistant HER2-positive breast tumors

吡咯替尼对曲妥珠单抗敏感和原发性耐药 HER2 阳性乳腺肿瘤均有效

期刊:Chinese Journal of Cancer Research
影响因子:1.200
doi:10.21147/j.issn.1000-9604.2024.02.03
Jialin Zhang, Gengshen Yin, Chunmiao Ye, Man Feng, Changhua Ji, Wenzhong Zhou, Fei Wang, Lixiang Yu, Shuya Huang, Zhigang Yu
肿瘤
乳腺癌
发表日期：2024
全文求助 收藏

Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.

基因异常有助于病理诊断，EBV阳性细胞密度影响中国血管免疫母细胞性T细胞淋巴瘤患者的生存

期刊:Chinese Journal of Cancer Research
影响因子:6.300
doi:10.21147/j.issn.1000-9604.2023.05.10
Shi Yunfei, Wang Haojie, Liu Yanfei, Long Mengping, Ding Ning, Mi Lan, Lai Yumei, Zhou Lixin, Diao Xinting, Li Xianghong, Liu Weiping, Zhu Jun
细胞生物学
淋巴瘤
T细胞
发表日期：2023
全文求助 收藏
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7